{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:15:55Z","timestamp":1780596955061,"version":"3.54.1"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.jtct.2022.07.017","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T12:52:40Z","timestamp":1658494360000},"page":"747.e1-747.e10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Characterization of Hepatic Dysfunction in Subjects Diagnosed With Chronic GVHD by NIH Consensus Criteria"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5975-5131","authenticated-orcid":false,"given":"Alexander H.","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2740-2486","authenticated-orcid":false,"given":"Ma Ai Thanda","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1993-5223","authenticated-orcid":false,"given":"Niharika","family":"Samala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisharah S.","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Marchalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9254-2154","authenticated-orcid":false,"given":"Ohad","family":"Etzion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9841-3879","authenticated-orcid":false,"given":"Elizabeth C.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances T.","family":"Hakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devika","family":"Kapuria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis D.","family":"Hickstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Kanakry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher G.","family":"Kanakry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David E.","family":"Kleiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven Z.","family":"Pavletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2643-6289","authenticated-orcid":false,"given":"Theo","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2022.07.017_bib0001","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/bmt.2014.75","article-title":"Complement component C3 mediates Th1\/Th17 polarization in human T-cell activation and cutaneous GVHD","volume":"49","author":"Ma","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0002","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.bbmt.2015.05.004","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report","volume":"21","author":"Martin","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0003","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/nri2000","article-title":"Graft-versus-host disease","volume":"7","author":"Shlomchik","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtct.2022.07.017_bib0004","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bbmt.2014.12.001","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group report","volume":"21","author":"Jagasia","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0006","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/sj.bmt.1703278","article-title":"Clinical importance of confirming or excluding the diagnosis of chronic graft-versus-host disease","volume":"28","author":"Jacobsohn","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0007","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bbmt.2010.07.017","article-title":"Diagnosis and staging of chronic graft-versus-host disease in the clinical practice","volume":"17","author":"Greinix","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0008","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.bmt.1704739","article-title":"Severe hypercholesterolemia mediated by lipoprotein X in patients with chronic graft-versus-host disease of the liver","volume":"35","author":"Turchin","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0009","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/hep.1840080305","article-title":"A coded histologic study of hepatic graft-versus-host disease after human bone marrow transplantation","volume":"8","author":"Shulman","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.jtct.2022.07.017_bib0010","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1053\/jhep.2000.20067","article-title":"Chronic graft-versus-host disease of the liver: presentation as an acute hepatitis","volume":"32","author":"Strasser","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.jtct.2022.07.017_bib0011","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bbmt.2014.01.010","article-title":"Validation of National Institutes of Health global scoring system for chronic graft-versus-host disease (GVHD) according to overall and GVHD-specific survival","volume":"20","author":"Moon","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0012","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/j.bbmt.2007.07.001","article-title":"Incidence and outcome of chronic graft-versus-host disease using National Institutes of Health consensus criteria","volume":"13","author":"Jagasia","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0013","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.bbmt.2014.12.031","article-title":"NIH Consensus development project on criteria for clinical trials in chronic graft-versus-host disease: II. The 2014 Pathology Working Group Report","volume":"21","author":"Shulman","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0014","first-page":"367","article-title":"Histopathology of graft-vs.-host reaction (GvHR) in human recipients of marrow from HL-A-matched sibling donors","volume":"6","author":"Lerner","year":"1974","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jtct.2022.07.017_bib0015","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.beha.2008.02.005","article-title":"GVHD pathophysiology: is acute different from chronic?","volume":"21","author":"Toubai","year":"2008","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1016\/j.jtct.2022.07.017_bib0016","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.bbmt.2015.01.003","article-title":"National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: III. The 2014 Biomarker Working Group Report","volume":"21","author":"Paczesny","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0017","doi-asserted-by":"crossref","first-page":"4472","DOI":"10.1182\/blood-2011-04-349068","article-title":"Risk factors associated with increased nonrelapse mortality and with poor overall survival in children with chronic graft-versus-host disease","volume":"118","author":"Jacobsohn","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.07.017_bib0018","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1182\/blood.V74.4.1428.1428","article-title":"Predictors of death from chronic graft-versus-host disease after bone marrow transplantation","volume":"74","author":"Wingard","year":"1989","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.07.017_bib0019","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/hep.20529","article-title":"Serum bilirubin levels and mortality after myeloablative allogeneic hematopoietic cell transplantation","volume":"41","author":"Gooley","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jtct.2022.07.017_bib0020","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1053\/j.gastro.2008.02.081","article-title":"Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease","volume":"134","author":"Feld","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jtct.2022.07.017_bib0021","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1056\/NEJMoa1007097","article-title":"Residual NADPH oxidase and survival in chronic granulomatous disease","volume":"363","author":"Kuhns","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2022.07.017_bib0022","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/leu.2011.254","article-title":"Clinical laboratory markers of inflammation as determinants of chronic graft-versus-host disease activity and NIH global severity","volume":"26","author":"Grkovic","year":"2012","journal-title":"Leukemia"},{"key":"10.1016\/j.jtct.2022.07.017_bib0023","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood-2011-04-350249","article-title":"Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease","volume":"118","author":"Martires","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2022.07.017_bib0024","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.bbmt.2012.05.014","article-title":"Reduced graft-versus-host disease in C3-deficient mice is associated with decreased donor Th1\/Th17 differentiation","volume":"18","author":"Ma","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0025","article-title":"Association between complement C3 and prevalence of fatty liver disease in an adult population: a cross-sectional study from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) cohort study","volume":"10","author":"Jia","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jtct.2022.07.017_bib0026","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.23228","article-title":"Activation of the complement system in human nonalcoholic fatty liver disease","volume":"50","author":"Rensen","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.jtct.2022.07.017_bib0027","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.yexmp.2014.09.004","article-title":"Increased activity of the complement system in the liver of patients with alcoholic hepatitis","volume":"97","author":"Shen","year":"2014","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.jtct.2022.07.017_bib0028","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/j.seminhematol.2011.10.003","article-title":"Management of high ferritin in long-term survivors after hematopoietic stem cell transplantation","volume":"49","author":"Brissot","year":"2012","journal-title":"Semin Hematol"},{"key":"10.1016\/j.jtct.2022.07.017_bib0029","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3109\/10428194.2013.842981","article-title":"Clinical significance of pre- and 1-year post-transplant serum ferritin among adult transplant recipients","volume":"55","author":"Tachibana","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jtct.2022.07.017_bib0030","doi-asserted-by":"crossref","first-page":"E168","DOI":"10.1111\/j.1399-0012.2012.01628.x","article-title":"Hyperlipidemia after allogeneic stem cell transplantation: prevalence, risk factors, and impact on prognosis","volume":"26","author":"Kagoya","year":"2012","journal-title":"Clin Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0031","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nri3212","article-title":"Advances in graft-versus-host disease biology and therapy","volume":"12","author":"Blazar","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jtct.2022.07.017_bib0032","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1200\/JCO.2008.17.1314","article-title":"Association of Serum Interleukin-7 Levels With the Development of Acute Graft-Versus-Host Disease","volume":"26","author":"Dean","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2022.07.017_bib0033","first-page":"13","article-title":"Emerging roles for IL-15 in the activation and function of T-cells during immune stimulation","volume":"6","author":"Anthony","year":"2015","journal-title":"Res Rep Biol"},{"key":"10.1016\/j.jtct.2022.07.017_bib0034","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/bmt.2010.13","article-title":"Plasma levels of IL-7 and IL-15 in the first month after myeloablative BMT are predictive biomarkers of both acute GVHD and relapse","volume":"45","author":"Thiant","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0035","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/bmt.2010.300","article-title":"Plasma levels of IL-7 and IL-15 after reduced intensity conditioned allo-SCT and relationship to acute GVHD","volume":"46","author":"Thiant","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0036","first-page":"9","article-title":"Characterization of serum interleukin-15 in healthy volunteers and patients with early arthritis to assess its potential use as a biomarker","volume":"21","author":"Lamana","year":"2010","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.jtct.2022.07.017_bib0037","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1089\/rej.2009.0863","article-title":"Elevated proportions of recent thymic emigrants in children and adolescents with type 1 diabetes","volume":"12","author":"Hofer","year":"2009","journal-title":"Rejuvenation Res"},{"key":"10.1016\/j.jtct.2022.07.017_bib0038","doi-asserted-by":"crossref","first-page":"12804","DOI":"10.1074\/jbc.M114.635763","article-title":"Hepatic serum amyloid A1 aggravates T cell-mediated hepatitis by inducing chemokines via Toll-like receptor 2 in mice","volume":"290","author":"Ji","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jtct.2022.07.017_bib0039","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gene.2016.02.044","article-title":"Serum amyloid A1: structure, function and gene polymorphism","volume":"583","author":"Sun","year":"2016","journal-title":"Gene"},{"key":"10.1016\/j.jtct.2022.07.017_bib0040","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1136\/jcp.45.4.348","article-title":"Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia","volume":"45","author":"Uguccioni","year":"1992","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.jtct.2022.07.017_bib0041","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1699-0463.1991.tb01245.x","article-title":"Serum amyloid A levels in acute graft-versus-host disease in bone marrow transplant recipients","volume":"99","author":"Leskinen","year":"1991","journal-title":"APMIS"},{"key":"10.1016\/j.jtct.2022.07.017_bib0042","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/bmt.2009.80","article-title":"Kinetics of Th1\/Th2 cytokines and lymphocyte subsets to predict chronic GVHD after allo-SCT: results of a prospective study","volume":"44","author":"Skert","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2022.07.017_bib0043","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00007890-199810150-00009","article-title":"Serum cytokine levels after HLA-identical bone marrow transplantation","volume":"66","author":"Liem","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.jtct.2022.07.017_bib0044","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1165\/ajrcmb\/5.2.155","article-title":"Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis","volume":"5","author":"Khalil","year":"1991","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.jtct.2022.07.017_bib0045","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1056\/NEJM199104043241401","article-title":"Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy","volume":"324","author":"Castilla","year":"1991","journal-title":"N Engl J Med"},{"issue":"Suppl 3","key":"10.1016\/j.jtct.2022.07.017_bib0046","first-page":"S88","article-title":"Matrix metalloproteinases, the pros and cons, in liver fibrosis","volume":"21","author":"Han","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.jtct.2022.07.017_bib0047","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.autrev.2005.02.006","article-title":"T cell immunity and graft-versus-host disease (GVHD)","volume":"5","author":"Ichiki","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.jtct.2022.07.017_bib0048","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1365-2141.2012.09128.x","article-title":"Diagnosis and management of chronic graft-versus-host disease","volume":"158","author":"Dignan","year":"2012","journal-title":"Br J Haematol"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722014786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636722014786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:03:38Z","timestamp":1763003018000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636722014786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2666636722014786"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2022.07.017","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of Hepatic Dysfunction in Subjects Diagnosed With Chronic GVHD by NIH Consensus Criteria","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2022.07.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of The American Society for Transplantation and Cellular Therapy.","name":"copyright","label":"Copyright"}]}}